...
机译:来自胶质瘤患者的肿瘤浸润淋巴细胞(TIL)
Karolinska Inst Dept Lab Med Therapeut Immunol Unit Stockholm Sweden;
Karolinska Inst Dept Lab Med Therapeut Immunol Unit Stockholm Sweden;
Karolinska Univ Hosp Dept Neurosurg Stockholm Sweden;
Karolinska Inst Dept Lab Med Therapeut Immunol Unit Stockholm Sweden;
Karolinska Univ Hosp Dept Neurosurg Stockholm Sweden;
Karolinska Inst Dept Lab Med Therapeut Immunol Unit Stockholm Sweden;
Karolinska Hosp Dept Clin Sci Intervent &
Technol Stockholm Sweden;
Karolinska Univ Hosp Dept Neurosurg Stockholm Sweden;
Karolinska Univ Hosp Dept Neurosurg Stockholm Sweden;
Karolinska Inst Dept Lab Med Therapeut Immunol Unit Stockholm Sweden;
Karolinska Inst Dept Lab Med Therapeut Immunol Unit Stockholm Sweden;
Karolinska Inst Dept Lab Med Therapeut Immunol Unit Stockholm Sweden;
Karolinska Univ Hosp Dept Neurosurg Stockholm Sweden;
Karolinska Inst Dept Lab Med Therapeut Immunol Unit Stockholm Sweden;
Brain tumor; cellular therapy; cytokines; glioma; TIL;
机译:来自胶质瘤患者的肿瘤浸润淋巴细胞(TIL)
机译:利用国际直到工件组(ITWG)系统评估肿瘤浸润淋巴细胞是一种强大的预测因素,其整体癌整体生存率是1034名患者的研究
机译:预测病理完全反应(PCR)和肿瘤浸润性淋巴细胞(TIL)的价值,以预测乳腺癌患者对新辅助化疗(NAC)的响应预测
机译:无标记的多光子成像,以鉴定乳腺肿瘤微环境中两种类型的肿瘤浸润淋巴细胞
机译:使用蛋白质干细胞转录因子对肿瘤浸润性细胞毒性T淋巴细胞的谱系重编程
机译:鉴定神经胶质瘤患者的肿瘤浸润淋巴细胞(TIL)识别的新表位
机译:校正:鉴定胶质瘤患者肿瘤浸润淋巴细胞(TIL)识别的新患者